扶正理气合剂治疗抗结核药物性肝炎的临床研究  

Clinical Study on Fuzheng-Liqi Mixture in the Treatment of Hepatitis Resulted from Anti-tuberculosis Drugs

作　　者：张超贤[1] 秦咏梅[1] 郭宝瑞[2] 

机构地区：[1]河南新乡医学院一附院消化科,卫辉453100 [2]新乡医学院一附院中医科,卫辉453100

出　　处：《国际中医中药杂志》2008年第4期280-281,共2页International Journal of Traditional Chinese Medicine

摘　　要：目的 探讨扶正理气合剂对抗结核药物性肝炎的临床疗效。方法 采用前瞻性研究，对2005年1月至2007年12月诊断为抗结核药物性肝炎100例住院患者随机分为治疗组和对照组，治疗组给予扶正理气合剂治疗，对照组进行常规治疗，疗效进行统计分析。结果 治疗组的疗效显著优于对照组。结论 扶正理气合剂可明显改善药物性肝炎的症状，恢复肝功能。Objective To explore the therapeutic effect of Fuzheng-Liqi mixture on hepatitis resulted from anti-tuberculosis drugs. Methods 100 inpatients of hepatitis resulted from anti-tuberculosis drugs during January 2005 to December 2007 were randomly sorted out into a treatment group and a control group. The treatment group was treated with Fuzheng-Liqi mixture, and the control group was treated with routine drugs. The effect was analyzed by X2 test. Results The therapeutic effect of the treatment group markedly excelled than the control group in terms of symptoms improvement such as nausea or vomit, tiredness, icterus, hepatalgia, or augment of liver. Conclusion Fuzheng-Liqi mixture was not only able to ameliorate the clinical manifestations of drug-induced hepatitis, but also improve hepatic function.

关 键 词：抗结核药物 药物性肝炎 扶正理气合剂 

分 类 号：R575[医药卫生—消化系统]